Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Storrs, Connecticut 06269


This research is being done is to evaluate the feasibility and acceptability of a novel weight loss mobile app that was designed to be less burdensome than traditional weight loss apps.

Study summary:

Obesity and stress are highly comorbid and both increase risk for cardiovascular disease (CVD). Stress is associated with disinhibited eating, junk food consumption and low consumption of produce and whole grains. Both stress and stress-induced eating are not only associated with obesity but also predict worst outcomes in lifestyle interventions. Stress and stress-induced eating should be targeted in interventions to maximize weight loss; however, this makes for a very intensive intervention. Technology could be leveraged to reduce intervention burden. In this trial investigators propose to compare the feasibility, usability, acceptability, and burden of an traditional weight loss app that includes diet and physical activity self-monitoring features to an app (Slip Buddy) we developed that focuses on self-monitoring of stress eating. With Slip Buddy, the user is just asked to track overeating episodes, indicating when they are triggered by stress. The majority of weight loss apps are burdensome to users by requiring them to self-monitor diet and exercise. They also ignore major barriers to weight loss, such as stress. This work moves the field forward by addressing user burden and an important barrier to weight loss.


Inclusion Criteria: - Phone connectivity at home and work - Have written clearance from their PCP - Willing to use the Nexus (Google) smartphone that runs on the Android operating system. Exclusion Criteria: 1. Under the age of 18 or over the age of 65; 2. BMI under 30 or over 45; 3. Does not currently own a smartphone; 4. Not phone connectivity at home and work; 5. Unable to collect medical clearance; 6. Unable to walk unaided for 1/4 mile without stopping; 7. Taking medications known to affect appetite and/or weight; 8. Has a condition which precludes dietary changes (i.e. ulcerative colitis, Crohn's disease, active diverticulitis, renal disease); 9. Type 1 or 2 diabetes; 10. Had gastric bypass surgery; 11. Plans to have gastric bypass surgery during the study period; 12. Pregnant/lactating; 13. Bipolar disorder, substance abuse, psychosis, bulimia, or severe depression; 14. Had bariatric surgery or recently lost significant weight; 15. On medication affecting weight; 16. Unwillingness of the patient's PCP to participate (phase 4 RELAX-AS condition only) 17. Prisoner; or 18. Unable to provide consent



Primary Contact:


Backup Contact:


Location Contact:

Storrs, Connecticut 06269
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.